{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:42:59Z","timestamp":1778002979558,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Evidence of the association between anemia and risk of PD (Parkinson\u2019s disease) have been accumulating. This study aimed to examine the relationship between anemia and risk of PD in Korean older adults. Korean adults aged 50 years or older who participated in the Korean National Screening Program (<jats:italic>n<\/jats:italic>\u2009=\u200912,342,278) between 2009 and 2013 were followed until 2015. Cox proportional hazards regression models were used to calculate the hazard ratio (HR) of PD, and participants were followed for a mean period of 5.0 years. At the end of follow-up, 3,844 adults were diagnosed with PD. After adjusting for potential confounders, participants with anemia had decreased risk of PD compared to adults without anemia (adjusted HR (aHR) 0.894, 95% CI: 0.809\u20130.989). Furthermore, aHR of PD was 0.698 (95% CI: 0.546\u20130.891) in moderate to severe anemia and 0.938 (95% CI: 0.843\u20131.044) in mild anemia. The protective effect of anemia was also more profound in men (aHR 0.888, 95% CI: 0.774\u20131.02) than in women (aHR 0.905, 95% CI: 0.782\u20131.048). In conclusion, anemia was associated with lower risk of PD, particularly for patients with moderate to severe anemia. Our study suggests that further studies may be needed to clarify the relationship between anemia and PD.<\/jats:p>","DOI":"10.1038\/s41598-020-61153-5","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T11:02:37Z","timestamp":1583492557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Anemia and the risk of Parkinson\u2019s disease in Korean older adults: A nationwide population-based study"],"prefix":"10.1038","volume":"10","author":[{"given":"In Young","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Wook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younjin","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4808-7083","authenticated-orcid":false,"given":"Wooyoung","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Whan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Ae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeonyoung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Hyun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"61153_CR1","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim, T., Jette, N., Frolkis, A. & Steeves, T. D. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 29, 1583\u20131590, https:\/\/doi.org\/10.1002\/mds.25945 (2014).","journal-title":"Mov. Disord."},{"key":"61153_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau, L. M. & Breteler, M. M. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 5, 525\u2013535, https:\/\/doi.org\/10.1016\/S1474-4422(06)70471-9 (2006).","journal-title":"Lancet Neurol."},{"key":"61153_CR3","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/mds.25955","volume":"29","author":"GW Ross","year":"2014","unstructured":"Ross, G. W. & Abbott, R. D. Living and dying with Parkinson\u2019s disease. Mov. Disord. 29, 1571\u20131573, https:\/\/doi.org\/10.1002\/mds.25955 (2014).","journal-title":"Mov. Disord."},{"key":"61153_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"SL Kowal","year":"2013","unstructured":"Kowal, S. L., Dall, T. M., Chakrabarti, R., Storm, M. V. & Jain, A. The current and projected economic burden of Parkinson\u2019s disease in the United States. Mov. Disord. 28, 311\u2013318, https:\/\/doi.org\/10.1002\/mds.25292 (2013).","journal-title":"Mov. Disord."},{"key":"61153_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00415-011-5969-1","volume":"258","author":"P Jennum","year":"2011","unstructured":"Jennum, P., Zoetmulder, M., Korbo, L. & Kjellberg, J. The health-related, social, and economic consequences of parkinsonism: a controlled national study. J. Neurol. 258, 1497\u20131506, https:\/\/doi.org\/10.1007\/s00415-011-5969-1 (2011).","journal-title":"J. Neurol."},{"key":"61153_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s40273-013-0075-0","volume":"31","author":"SJ Johnson","year":"2013","unstructured":"Johnson, S. J. et al. Costs of Parkinson\u2019s disease in a privately insured population. Pharmacoeconomics 31, 799\u2013806, https:\/\/doi.org\/10.1007\/s40273-013-0075-0 (2013).","journal-title":"Pharmacoeconomics"},{"key":"61153_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/srep29651","volume":"6","author":"CT Hong","year":"2016","unstructured":"Hong, C. T. et al. Newly Diagnosed Anemia Increases Risk of Parkinson\u2019s disease: A Population-Based Cohort Study. Sci. Rep. 6, 29651, https:\/\/doi.org\/10.1038\/srep29651 (2016).","journal-title":"Sci. Rep."},{"key":"61153_CR8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1212\/WNL.0b013e3181bd80c1","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica, R. et al. Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurol. 73, 1381\u20131387, https:\/\/doi.org\/10.1212\/WNL.0b013e3181bd80c1 (2009).","journal-title":"Neurol."},{"key":"61153_CR9","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.neurobiolaging.2010.06.023","volume":"33","author":"RD Abbott","year":"2012","unstructured":"Abbott, R. D. et al. Late-life hemoglobin and the incidence of Parkinson\u2019s disease. Neurobiol. Aging 33, 914\u2013920, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.06.023 (2012).","journal-title":"Neurobiol. Aging"},{"key":"61153_CR10","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1212\/01.wnl.0000068021.13945.7f","volume":"60","author":"KM Powers","year":"2003","unstructured":"Powers, K. M. et al. Parkinson\u2019s disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurol. 60, 1761\u20131766, https:\/\/doi.org\/10.1212\/01.wnl.0000068021.13945.7f (2003).","journal-title":"Neurol."},{"key":"61153_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.neurobiolaging.2012.05.015","volume":"34","author":"S Mariani","year":"2013","unstructured":"Mariani, S. et al. Fe and Cu do not differ in Parkinson\u2019s disease: a replication study plus meta-analysis. Neurobiol. Aging 34, 632\u2013633, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.05.015 (2013).","journal-title":"Neurobiol. Aging"},{"key":"61153_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s007020050001","volume":"107","author":"KA Jellinger","year":"2000","unstructured":"Jellinger, K. A. Cell death mechanisms in Parkinson\u2019s disease. J. Neural Transm. 107, 1\u201329, https:\/\/doi.org\/10.1007\/s007020050001 (2000).","journal-title":"J. Neural Transm."},{"key":"61153_CR13","doi-asserted-by":"publisher","unstructured":"Tatton, W. G., Chalmers-Redman, R., Brown, D. & Tatton, N. Apoptosis in Parkinson\u2019s disease: signals for neuronal degradation. Ann Neurol 53 Suppl 3, S61\u201370, discussion S70-62, https:\/\/doi.org\/10.1002\/ana.10489 (2003).","DOI":"10.1002\/ana.10489"},{"key":"61153_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/mds.20362","volume":"20","author":"JE Ahlskog","year":"2005","unstructured":"Ahlskog, J. E. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson\u2019s disease. Mov. Disord. 20, 271\u2013282, https:\/\/doi.org\/10.1002\/mds.20362 (2005).","journal-title":"Mov. Disord."},{"key":"61153_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuroscience.2014.09.071","volume":"284","author":"LH You","year":"2015","unstructured":"You, L. H. et al. Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson\u2019s disease. Neurosci. 284, 234\u2013246, https:\/\/doi.org\/10.1016\/j.neuroscience.2014.09.071 (2015).","journal-title":"Neurosci."},{"key":"61153_CR16","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1212\/WNL.0b013e3181a26b30","volume":"72","author":"EE Benarroch","year":"2009","unstructured":"Benarroch, E. E. Brain iron homeostasis and neurodegenerative disease. Neurol. 72, 1436\u20131440, https:\/\/doi.org\/10.1212\/WNL.0b013e3181a26b30 (2009).","journal-title":"Neurol."},{"key":"61153_CR17","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1212\/01.wnl.0000262033.01945.9a","volume":"68","author":"AE Oakley","year":"2007","unstructured":"Oakley, A. E. et al. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurol. 68, 1820\u20131825, https:\/\/doi.org\/10.1212\/01.wnl.0000262033.01945.9a (2007).","journal-title":"Neurol."},{"key":"61153_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2011.12.054","volume":"46","author":"P Dusek","year":"2012","unstructured":"Dusek, P., Jankovic, J. & Le, W. Iron dysregulation in movement disorders. Neurobiol. Dis. 46, 1\u201318, https:\/\/doi.org\/10.1016\/j.nbd.2011.12.054 (2012).","journal-title":"Neurobiol. Dis."},{"key":"61153_CR19","doi-asserted-by":"publisher","first-page":"e0146129","DOI":"10.1371\/journal.pone.0146129","volume":"11","author":"MS Medeiros","year":"2016","unstructured":"Medeiros, M. S. et al. Iron and Oxidative Stress in Parkinson\u2019s Disease: An Observational Study of Injury Biomarkers. PLoS One 11, e0146129, https:\/\/doi.org\/10.1371\/journal.pone.0146129 (2016).","journal-title":"PLoS One"},{"key":"61153_CR20","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/j.freeradbiomed.2012.08.569","volume":"53","author":"R Perfeito","year":"2012","unstructured":"Perfeito, R., Cunha-Oliveira, T. & Rego, A. C. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease\u2013resemblance to the effect of amphetamine drugs of abuse. Free. Radic. Biol. Med. 53, 1791\u20131806, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.08.569 (2012).","journal-title":"Free. Radic. Biol. Med."},{"key":"61153_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nature04782","volume":"441","author":"T Uehara","year":"2006","unstructured":"Uehara, T. et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nat. 441, 513\u2013517, https:\/\/doi.org\/10.1038\/nature04782 (2006).","journal-title":"Nat."},{"key":"61153_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/ars.2013.5593","volume":"21","author":"D Devos","year":"2014","unstructured":"Devos, D. et al. Targeting chelatable iron as a therapeutic modality in Parkinson\u2019s disease. Antioxid. Redox Signal. 21, 195\u2013210, https:\/\/doi.org\/10.1089\/ars.2013.5593 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"61153_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.freeradbiomed.2013.01.017","volume":"62","author":"O Weinreb","year":"2013","unstructured":"Weinreb, O., Mandel, S., Youdim, M. B. & Amit, T. Targeting dysregulation of brain iron homeostasis in Parkinson\u2019s disease by iron chelators. Free. Radic. Biol. Med. 62, 52\u201364, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.01.017 (2013).","journal-title":"Free. Radic. Biol. Med."},{"key":"61153_CR24","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1523\/JNEUROSCI.3439-14.2015","volume":"35","author":"S Ayton","year":"2015","unstructured":"Ayton, S. et al. Parkinson\u2019s disease iron deposition caused by nitric oxide-induced loss of beta-amyloid precursor protein. J. Neurosci. 35, 3591\u20133597, https:\/\/doi.org\/10.1523\/JNEUROSCI.3439-14.2015 (2015).","journal-title":"J. Neurosci."},{"key":"61153_CR25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrn1537","volume":"5","author":"L Zecca","year":"2004","unstructured":"Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R. & Crichton, R. R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863\u2013873, https:\/\/doi.org\/10.1038\/nrn1537 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"61153_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00702-010-0470-z","volume":"118","author":"RR Crichton","year":"2011","unstructured":"Crichton, R. R., Dexter, D. T. & Ward, R. J. Brain iron metabolism and its perturbation in neurological diseases. J. Neural Transm. 118, 301\u2013314, https:\/\/doi.org\/10.1007\/s00702-010-0470-z (2011).","journal-title":"J. Neural Transm."},{"key":"61153_CR27","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nat. 388, 839\u2013840, https:\/\/doi.org\/10.1038\/42166 (1997).","journal-title":"Nat."},{"key":"61153_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","volume":"5","author":"R Barbour","year":"2008","unstructured":"Barbour, R. et al. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener. Dis. 5, 55\u201359, https:\/\/doi.org\/10.1159\/000112832 (2008).","journal-title":"Neurodegener. Dis."},{"key":"61153_CR29","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.imbio.2014.07.014","volume":"219","author":"W Xiao","year":"2014","unstructured":"Xiao, W., Shameli, A., Harding, C. V., Meyerson, H. J. & Maitta, R. W. Late stages of hematopoiesis and B cell lymphopoiesis are regulated by alpha-synuclein, a key player in Parkinson\u2019s disease. Immunobiology 219, 836\u2013844, https:\/\/doi.org\/10.1016\/j.imbio.2014.07.014 (2014).","journal-title":"Immunobiology"},{"key":"61153_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep02540","volume":"3","author":"PG Foulds","year":"2013","unstructured":"Foulds, P. G. et al. A longitudinal study on alpha-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease. Sci. Rep. 3, 2540, https:\/\/doi.org\/10.1038\/srep02540 (2013).","journal-title":"Sci. Rep."},{"key":"61153_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neulet.2015.05.030","volume":"599","author":"X Wang","year":"2015","unstructured":"Wang, X., Yu, S., Li, F. & Feng, T. Detection of alpha-synuclein oligomers in red blood cells as a potential biomarker of Parkinson\u2019s disease. Neurosci. Lett. 599, 115\u2013119, https:\/\/doi.org\/10.1016\/j.neulet.2015.05.030 (2015).","journal-title":"Neurosci. Lett."},{"key":"61153_CR32","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/jnnp-2015-312283","volume":"87","author":"F Moisan","year":"2016","unstructured":"Moisan, F. et al. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J. Neurol. Neurosurg. Psychiatry 87, 952\u2013957, https:\/\/doi.org\/10.1136\/jnnp-2015-312283 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"61153_CR33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.yhbeh.2012.05.013","volume":"63","author":"R Savica","year":"2013","unstructured":"Savica, R., Grossardt, B. R., Bower, J. H., Ahlskog, J. E. & Rocca, W. A. Risk factors for Parkinson\u2019s disease may differ in men and women: an exploratory study. Horm. Behav. 63, 308\u2013314, https:\/\/doi.org\/10.1016\/j.yhbeh.2012.05.013 (2013).","journal-title":"Horm. Behav."},{"key":"61153_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.archger.2015.08.004","volume":"61","author":"X Li","year":"2015","unstructured":"Li, X., Li, W., Liu, G., Shen, X. & Tang, Y. Association between cigarette smoking and Parkinson\u2019s disease: A meta-analysis. Arch. Gerontol. Geriatr. 61, 510\u2013516, https:\/\/doi.org\/10.1016\/j.archger.2015.08.004 (2015).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"61153_CR35","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/aje\/155.8.732","volume":"155","author":"H Checkoway","year":"2002","unstructured":"Checkoway, H. et al. Parkinson\u2019s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am. J. Epidemiol. 155, 732\u2013738, https:\/\/doi.org\/10.1093\/aje\/155.8.732 (2002).","journal-title":"Am. J. Epidemiol."},{"key":"61153_CR36","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/ije\/dyy230","volume":"48","author":"V Gallo","year":"2019","unstructured":"Gallo, V. et al. Exploring causality of the association between smoking and Parkinson\u2019s disease. Int. J. Epidemiol. 48, 912\u2013925, https:\/\/doi.org\/10.1093\/ije\/dyy230 (2019).","journal-title":"Int. J. Epidemiol."},{"key":"61153_CR37","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/mds.25028","volume":"27","author":"M Quik","year":"2012","unstructured":"Quik, M., Perez, X. A. & Bordia, T. Nicotine as a potential neuroprotective agent for Parkinson\u2019s disease. Mov. Disord. 27, 947\u2013957, https:\/\/doi.org\/10.1002\/mds.25028 (2012).","journal-title":"Mov. Disord."},{"key":"61153_CR38","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.bcp.2007.07.032","volume":"74","author":"SR Grady","year":"2007","unstructured":"Grady, S. R. et al. The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem. Pharmacol. 74, 1235\u20131246, https:\/\/doi.org\/10.1016\/j.bcp.2007.07.032 (2007).","journal-title":"Biochem. Pharmacol."},{"key":"61153_CR39","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s00415-018-9032-3","volume":"266","author":"FJ Jimenez-Jimenez","year":"2019","unstructured":"Jimenez-Jimenez, F. J., Alonso-Navarro, H., Garcia-Martin, E. & Agundez, J. A. G. Alcohol consumption and risk for Parkinson\u2019s disease: a systematic review and meta-analysis. J. Neurol. 266, 1821\u20131834, https:\/\/doi.org\/10.1007\/s00415-018-9032-3 (2019).","journal-title":"J. Neurol."},{"key":"61153_CR40","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/mds.25863","volume":"29","author":"D Zhang","year":"2014","unstructured":"Zhang, D., Jiang, H. & Xie, J. Alcohol intake and risk of Parkinson\u2019s disease: a meta-analysis of observational studies. Mov. Disord. 29, 819\u2013822, https:\/\/doi.org\/10.1002\/mds.25863 (2014).","journal-title":"Mov. Disord."},{"key":"61153_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cccn.2005.01.024","volume":"356","author":"T Yamamoto","year":"2005","unstructured":"Yamamoto, T., Moriwaki, Y. & Takahashi, S. Effect of ethanol on metabolism of purine bases (hypoxanthine, xanthine, and uric acid). Clin. Chim. Acta 356, 35\u201357, https:\/\/doi.org\/10.1016\/j.cccn.2005.01.024 (2005).","journal-title":"Clin. Chim. Acta"},{"key":"61153_CR42","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272, https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7 (2016).","journal-title":"Lancet Neurol."},{"key":"61153_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ypmed.2014.11.007","volume":"70","author":"H Lee","year":"2015","unstructured":"Lee, H. et al. Association of cardiovascular health screening with mortality, clinical outcomes, and health care cost: a nationwide cohort study. Prev. Med. 70, 19\u201325, https:\/\/doi.org\/10.1016\/j.ypmed.2014.11.007 (2015).","journal-title":"Prev. Med."},{"key":"61153_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.15656\/kjcg.2017.18.2.95","volume":"18","author":"SJ Wang","year":"2017","unstructured":"Wang, S. J. et al. Chronic kidney disease: a risk factor for parkinson\u2019s disease. Korean J. Clin. Geriatr. 18, 95\u2013101, https:\/\/doi.org\/10.15656\/kjcg.2017.18.2.95 (2017).","journal-title":"Korean J. Clin. Geriatr."},{"key":"61153_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000358921","volume":"42","author":"IK Wang","year":"2014","unstructured":"Wang, I. K. et al. Increased risk of Parkinson\u2019s disease in patients with end-stage renal disease: a retrospective cohort study. Neuroepidemiology 42, 204\u2013210, https:\/\/doi.org\/10.1159\/000358921 (2014).","journal-title":"Neuroepidemiology"},{"key":"61153_CR46","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","volume":"162","author":"BC Astor","year":"2002","unstructured":"Astor, B. C., Muntner, P., Levin, A., Eustace, J. A. & Coresh, J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988\u20131994). Arch. Intern. Med. 162, 1401\u20131408 (2002).","journal-title":"Arch. Intern. Med."},{"key":"61153_CR47","doi-asserted-by":"publisher","unstructured":"Nam, G. E. et al. Chronic renal dysfunction, proteinuria, and risk of Parkinson\u2019s disease in the elderly. Mov Disord, https:\/\/doi.org\/10.1002\/mds.27704 (2019).","DOI":"10.1002\/mds.27704"},{"key":"61153_CR48","unstructured":"World Health Organization, Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. (Health Communications Australia, 2000), https:\/\/apps.who.int\/iris\/handle\/10665\/206936 (2019)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61153-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:00:14Z","timestamp":1670313614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61153-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61153"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61153-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"8 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4268"}}